Rhenman & Partners Asset Management’s Immunogen Inc IMGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-700,000
| Closed | -$11.1M | – | 99 |
|
|
2023
Q3 | $11.1M | Sell |
700,000
-50,000
| -7% | -$794K | 1.2% | 31 |
|
|
2023
Q2 | $14.2M | Sell |
750,000
-500,000
| -40% | -$9.44M | 1.49% | 30 |
|
|
2023
Q1 | $4.64M | Sell |
1,250,000
-250,000
| -17% | -$928K | 0.51% | 57 |
|
|
2022
Q4 | $7.44M | Buy |
1,500,000
+400,000
| +36% | +$1.98M | 0.78% | 50 |
|
|
2022
Q3 | $6.53M | Sell |
1,100,000
-100,000
| -8% | -$594K | 0.68% | 52 |
|
|
2022
Q2 | $5.4M | Sell |
1,200,000
-225,000
| -16% | -$1.01M | 0.61% | 51 |
|
|
2022
Q1 | $6.78M | Sell |
1,425,000
-75,000
| -5% | -$357K | 0.67% | 52 |
|
|
2021
Q4 | $11.2M | Buy |
1,500,000
+281,150
| +23% | +$2.09M | 0.74% | 49 |
|
|
2021
Q3 | $6.91M | Hold |
1,218,850
| – | – | 0.49% | 63 |
|
|
2021
Q2 | $8.03M | Buy |
1,218,850
+668,850
| +122% | +$4.41M | 0.55% | 61 |
|
|
2021
Q1 | $4.46M | Buy |
+550,000
| New | +$4.46M | 0.31% | 78 |
|
|
2014
Q4 | – | Sell |
-180,000
| Closed | -$1.91M | – | 96 |
|
|
2014
Q3 | $1.91M | Buy |
180,000
+81,298
| +82% | +$861K | 0.56% | 74 |
|
|
2014
Q2 | $1.17M | Buy |
98,702
+25,000
| +34% | +$296K | 0.35% | 85 |
|
|
2014
Q1 | $1.1M | Sell |
73,702
-26,298
| -26% | -$392K | 0.33% | 77 |
|
|
2013
Q4 | $1.47M | Buy |
+100,000
| New | +$1.47M | 0.57% | 69 |
|